Loading asset research
XORTX Therapeutics Inc. Common Shares
XRTXNasdaq · USD · StocksQuote as of · Exchange session not verified$2.33
+10.43%
Today
XRTX
Loading 1D prices…
Market cap
$4.2M
Volume
1.9M
52w high
$7.0552w low
$1.73Company profile
XORTX Therapeutics Inc. Common Shares
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Calgary, AB, United States
Fiscal year end
1231
CIK
1729214
Session & valuation
Open$2.41
Previous close$2.11
Day high$2.45
Day low$2.17
30-day avg. volume122.9K
Outstanding shares13M
Diluted EPS-$2.80
Latest annual period
P/E (trailing)-0.83
P/E (forward)2.91
Price / book1.56
Beta0.44
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| GOVXGeoVax Labs Inc. Common Stock | $4.2M | $2.5M | -862.34% | -$22.40 | +0.71% | Buy |
| GRIGRI Bio Inc. Common Stock | $4.2M | $0.00 | — | -$121.80 | -3.09% | Buy |
| HCWBHCW Biologics Inc. Common Stock | $4.1M | $54.2K | -14677.14% | -$10.63 | -7.82% | Buy |
| SBFMSunshine Biopharma Inc. Common Stock | $4.1M | $36.3M | -16.46% | -$14.40 | -1.85% | Buy |
| ADXNAddex Therapeutics Ltd American Depositary Shares | $4.4M | — | — | -$7.20 | +2.95% | Unrated |